Teladoc Health (STU:4LL) Current Accrued Expense: €100 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4LL Teladoc Health Inc STU:4LL
59 GF Score
Price €5.59
GF Value €7.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Teladoc Health Current Accrued Expense?

Teladoc Health STU:4LL +2.57% 59 Current Accrued Expense is €100 Mil as of Jun. 2026. GuruFocus rates STU:4LL with a GF Score™ of 59/100 and a GF Value™ of €7.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Teladoc Health's Current Accrued Expense for the quarter that ended in Jun. 2026 was €100 Mil.

Teladoc Health's quarterly Current Accrued Expense increased from Dec. 2025 (€96 Mil) to Mar. 2026 (€104 Mil) but then declined from Mar. 2026 (€104 Mil) to Jun. 2026 (€100 Mil).

Teladoc Health's annual Current Accrued Expense increased from Dec. 2023 (€107 Mil) to Dec. 2024 (€125 Mil) but then declined from Dec. 2024 (€125 Mil) to Dec. 2025 (€96 Mil).

Teladoc Health Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Teladoc Health's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teladoc Health Current Accrued Expense Chart

Teladoc Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.45 90.09 107.14 125.34 95.53

Teladoc Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.58 104.95 95.53 103.65 100.13
STU:4LL
59GF Score
Teladoc Health Inc STU:4LL
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teladoc Health Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of €100 Mil mean?
Teladoc Health (STU:4LL) has a Current Accrued Expense of €100 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Teladoc Health and its competitors.
Is Teladoc Health's Current Accrued Expense too high?
Teladoc Health's current Current Accrued Expense is €100 Mil. Overall, Teladoc Health has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's Current Accrued Expense compare to OMCL and OMDA?
Teladoc Health's Current Accrued Expense of €100 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Healthcare Providers & Services company?
A good Current Accrued Expense depends on the Healthcare Providers & Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Teladoc Health and its competitors. Teladoc Health's current Current Accrued Expense is €100 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.07, compared to a current price of €5.59 — trading 20.9% below its estimated fair value. The current Current Accrued Expense is €100 Mil. Teladoc Health's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current Current Accrued Expense is €100 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teladoc Health (STU:4LL) Overvalued in 2026?

Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued. The current stock price of €5.59 is trading 20.9% below its estimated GF Value™ of €7.07. GuruFocus considers Teladoc Health to be Modestly Undervalued.

Key valuation signals for STU:4LL:

  • Current Accrued Expense: €100 Mil
  • GF Value™: €7.07 vs. price of €5.59 (20.9% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teladoc Health Business Description

Address 155 East 44th Street, Suite 1700, New York, NY, USA, 10017
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
59GF Score

Get the complete analysis for STU:4LL

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.59
Price
€7.07
GF Value